Cargando…

Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study

OBJECTIVES: Quantitative MRI (qMRI) of muscles is a promising tool to measure disease progression or to assess therapeutic effects in neuromuscular diseases. Longitudinal imaging studies are needed to show sensitivity of qMRI in detecting disease progression in spinal muscular atrophy (SMA). In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otto, Louise A.M., Froeling, Martijn, van Eijk, Ruben P.A., Asselman, Fay‐Lynn, Wadman, Renske, Cuppen, Inge, Hendrikse, Jeroen, van der Pol, W‐Ludo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988555/ https://www.ncbi.nlm.nih.gov/pubmed/33480130 http://dx.doi.org/10.1002/nbm.4473

Ejemplares similares

Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3
por: Otto, Louise A.M., et al.
Publicado: (2020)

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol
por: Ros, Leandra A. A., et al.
Publicado: (2023)

Natural history of lung function in spinal muscular atrophy
por: Wijngaarde, Camiel A., et al.
Publicado: (2020)

Relative hyperventilation in non-ventilated patients with spinal muscular atrophy
por: Veldhoen, Esther S., et al.
Publicado: (2020)

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study
por: Scheijmans, Féline E V, et al.
Publicado: (2022)

Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2022)

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2023)

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
por: Stam, Marloes, et al.
Publicado: (2022)

Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2019)

Parents’ perspectives on nusinersen treatment for children with spinal muscular atrophy
por: van Kruijsbergen, Mette, et al.
Publicado: (2021)

Respiratory muscle fatigability in patients with spinal muscular atrophy
por: Kant‐Smits, Kim, et al.
Publicado: (2022)

Feasibility and tolerability of multimodal peripheral electrophysiological techniques in a cohort of patients with spinal muscular atrophy
por: Ros, Leandra A.A., et al.
Publicado: (2023)

Multi‐parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophy
por: Hooijmans, Melissa T., et al.
Publicado: (2022)

Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests
por: Bartels, Bart, et al.
Publicado: (2020)

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018)

The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial
por: Kant-Smits, Kim, et al.
Publicado: (2023)

Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy
por: Habets, Laura E, et al.
Publicado: (2021)

Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy
por: Strunk, Annuska, et al.
Publicado: (2019)

Mastication in Patients with Spinal Muscular Atrophy Types 2 and 3 is Characterized by Abnormal Efficiency, Reduced Endurance, and Fatigue
por: van der Heul, A. M. B., et al.
Publicado: (2021)

Limited maximal mouth opening in patients with spinal muscular atrophy complicates endotracheal intubation: An observational study
por: Wijngaarde, Camiel A., et al.
Publicado: (2018)

A continuous repetitive task to detect fatigability in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2018)

Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies
por: van Rosmalen, Marieke H. J., et al.
Publicado: (2020)

Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron disease
por: van Rosmalen, Marieke H. J., et al.
Publicado: (2021)

SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis
por: Bos, Jeroen W., et al.
Publicado: (2021)

Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy
por: Wadman, Renske I, et al.
Publicado: (2020)

Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests
por: Bartels, Bart, et al.
Publicado: (2019)

Innovating spinal muscular atrophy models in the therapeutic era
por: Signoria, Ilaria, et al.
Publicado: (2023)

Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy
por: Wadman, Renske I., et al.
Publicado: (2019)

A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls
por: Wadman, Renske I., et al.
Publicado: (2016)

Cardiac pathology in spinal muscular atrophy: a systematic review
por: Wijngaarde, C. A., et al.
Publicado: (2017)

Low interrater reliability of brachial plexus MRI in chronic inflammatory neuropathies
por: van Rosmalen, Marieke H. J., et al.
Publicado: (2020)

‘This battle, between your gut feeling and your mind. Try to find the right balance’: Parental experiences of children with spinal muscular atrophy during COVID‐19 pandemic
por: Oude Lansink, Irene L. B., et al.
Publicado: (2022)

MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy
por: Haakma, Wieke, et al.
Publicado: (2016)

Spinal Muscular Atrophy Patient iPSC-Derived Motor Neurons Display Altered Proteomes at Early Stages of Differentiation
por: Varderidou-Minasian, Suzy, et al.
Publicado: (2021)

European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
por: Kirschner, Janbernd, et al.
Publicado: (2020)

Reduced parenchymal cerebral blood flow is associated with greater progression of brain atrophy: The SMART-MR study
por: Ghaznawi, Rashid, et al.
Publicado: (2020)

GEMINs: potential therapeutic targets for spinal muscular atrophy?
por: Borg, Rebecca, et al.
Publicado: (2014)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Cannot write session to /tmp/vufind_sessions/sess_5unf7aj3haebsdjvd6kufdqm3s